ABSTRACT-We evaluated the effect of the iron chelator deferoxamine on lipid peroxidation produced by the nephrotoxic antineoplastic drug cisplatin in rat kidney cortical slices. The addition of deferoxamine to the incubation medium prevented such lipid peroxidation in the incubated slices. Treatment of rats with deferoxamine inhib ited the increase in lipid peroxidation caused by cisplatin in the medium. These results suggest that iron may be a causal agent of cisplatin-induced lipid peroxidation.
cis-Diamminedichloroplatinum II (cisplatin), a nephrotoxic antineoplastic drug, stimulates lipid peroxidation in renal cortical slices (1, 2). Lipid peroxidation occurs when reactive ox ygen species react with polyunsaturated fatty acids in biological membranes (3) . The Haber Weiss reaction, in which superoxide radicals and hydrogen peroxide yield hydroxyl radicals, is accelerated by transition metals, particularly iron (4). The highly reactive hydroxyl radicals eventually initiate lipid peroxidation. Deferox amine, a potent iron chelator, inhibits the Haber-Weiss reaction (5) and thus can be used to study a process that seems to involve reac tive oxygen species, especially hydroxyl radi cals.
The purpose of this study was to examine the effect of deferoxamine on lipid peroxida tion in renal cortical slices incubated with cis platin. We wanted to find whether iron chela tion by deferoxamine would inhibit the lipid peroxidation caused by cisplatin.
Male Sprague-Dawley rats weighing 180 250 g were anesthetized with sodium pentobar bital (50 mg/kg, i.p.). Slices were prepared from kidney cortices of the rats with the use of a razor blade. In the first experiment, we incubated kidney cortical slices prepared from untreated rats at 37°C in medium with cis platin, deferoxamine, or both. In the next ex periments, slices prepared from rats 30 min after a single injection of deferoxamine (300 mg/kg, i.v.) were incubated at 37°C in medium with cisplatin or ethylenediaminetetra acetate (EDTA)-iron complex to evaluate the in vivo effects of the iron chelator. Ferric EDTA or ferrous-EDTA was prepared by mixing equimolar amounts of Na2H2EDTA and FeCl3 or FeCl2 (6) .
Slices were incubated in a medium contain ing 137 mM NaCI, 5.9 mM KCI, 1.5 mM CaClz, 1.2 mM MgCI2, 11.5 mM glucose, and 5.8 mM N-2-hydroxyethyl-piperazine-N'-ethane sulfonic acid titrated with NaOH to pH 7.4, as described previously (7) . When the incubation was over, the slices were removed from the medium, weighed, and homogenized in 20 mM Tris-HCI buffer (pH 7.4) containing 150 mM KCl and 3 mM EDTA. Lipid peroxidation in homogenates of the incubated slices was moni tored by measuring the malondialdehyde pro duction by the thiobarbituric acid assay de scribed by Buege and Aust (8) . Glutathione (GSH) as a nonprotein sulfhydryl in the homogenates was assayed by the method of Ellman (9) .
Cisplatin and deferoxamine mesylate were purchased from Sigma Chemical Co. (St. Louis, MO). Other chemicals were of the highest purity available from commercial sources. Data are expressed as means ± S.E. Statistical analyses were done by Student's t test.
The effects of cisplatin and deferoxamine on the malondialdehyde (lipid peroxide) and GSH levels in rat kidney cortical slices are shown in Fig. 1 . Incubation of the slices with 2 mM cisplatin for 90 min significantly increased the malondialdehyde level in the slices from control values of 31.5 ± 1.2 nmol/g wet wt. to 42.4 ± 1.1 nmol/g wet wt. Deferoxamine (0.1 mM) completely prevented the lipid peroxida tion caused by cisplatin. Deferoxamine alone had no effect on lipid peroxidation in the slices. Cisplatin markedly decreased the GSH level in the slices during the incubation. De feroxamine had no effect on the decrease in GSH level caused by cisplatin. Cellular GSH is well-known to be important in the protec tion of cells from free radicals and peroxides. However, the prevention by deferoxamine of cisplatin-induced lipid peroxidation was not accompanied by a recovery of the decrease in the GSH level in this study. The next experi ments were done to study the effect of treat ing rats with deferoxamine on lipid peroxida tion in kidney cortical slices incubated in the presence of cisplatin or iron in the medium (Fig. 2) . Lipid peroxidation was increased in the slices from the control-group that were in cubated not only in the presence of cisplatin in the medium as mentioned above but also in the presence of ferrous ion chelated with EDTA, although Fe 3+-EDTA did not affect lipid peroxidation in the slices. Deferoxamine treatment completely prevented this increase in lipid peroxidation in the slices incubated with cisplatin or Fe 2+-EDTA. The deferox amine treatment itself had no effect on the level of lipid peroxidation in the incubated slices. The results showed that the addition of de feroxamine to the medium completely pre vented the increase in lipid peroxidation pro duced by cisplatin in rat kidney cortical slices without any effect on the level of the cellular antioxidant GSH. This was also shown by the improved effect obtained in the slices incu bated in the presence of not only cisplatin but also Fe '+-EDTA when deferoxamine was in jected into the rats. So, we excluded a direct effect of deferoxamine on the assay of malon dialdehyde levels and demonstrated that de feroxamine, which was previously adminis tered to rats, inactivated ferrous ion by chelat ing it. Deferoxamine, which has a high affinity for iron (10) , inactivates this important catalyst, which is responsible for the genera tion of hydroxyl radicals in the Haber-Weiss and Fenton reactions (5) . These results can be explained by the hypothesis that iron plays a significant role in cisplatin-induced lipid perox idation in renal cells. Most of the iron in tis sues is stored safely in cells as ferric hydroxide micelles within ferritin molecules (11) . Reduc tion of the iron stored as ferritin in the form of ferric iron to the ferrous form results in its mobilization (4) . Release of iron from ferritin can be mediated by xanthine oxidase, primari ly via superoxide radicals (12, 13) . Iron is re leased from its storage pool and redistributed to reactive pool for catalysis of oxygen-derived free radical-mediated lipid peroxidation within renal tissues during ischemia and subsequent reperfusion of the kidney (14, 15) , whereby oxygen free radicals probably contribute to kidney damage. Perhaps iron can be released from ferritin in renal cells by cisplatin. Our re sults suggest that the beneficial effect of de feroxamine on the cisplatin-induced lipid perox idation may be due to its chelation of iron in renal cells, thereby inhibiting hydroxyl radical formation in the cells. 
